Abstract Objective: The aim of the present study was to analyze our results of treating synthetic vascular graft infection in the aorto-femoral segment with venous allografts. Patients and methods: During 1997e2006 we treated 11 male patients with venous allografts for aorto-femoral segment prosthetic graft infection. Patients were followed postoperatively with patency assessment based on Doppler ultrasonography. Results: The mean interval between the implantation of the synthetic vascular graft and the appearance of infection was 43 AE 29 months (range 5 monthse10 years). Overall primary patency of the venous allograft was 100%, 88% and 66% at 1, 6 and 36 months, respectively. Secondary patency rates of the venous allograft were 94% and 73% after 5 and 8 years, respectively. Overall survival rate was 100%, 64%, 46% and 27% after one month, 3, 5 and 8 years, respectively. Limb salvage rate was 100%, 94% and 73% after 1 month, 5 and 8 years, respectively. Conclusions: The use of in situ venous allograft for the treatment of synthetic graft infection in the aorto-femoral segment has led to favourable short-and long-term results. ª
Introduction
The incidence of synthetic vascular graft infection is up to 6%. 1 Synthetic vascular graft infection is one of the most serious complications in vascular surgery, associated with a mortality up to 50%, amputation rate up to 20% 2, 3 and an incidence of re-infection up to 22%. 3, 4 Several options have been proposed to treat this problem including both alloand auto-grafts. Within recent years Rifampicin-bonded or Silver-coated synthetic vascular grafts have been used. 4, 5 With Rifampicin-bonded and silver-coated vascular grafts the incidence of reinfection was 9e11% and 3.7e6.5% while postoperative mortality was 8e18% and 6.5e16.6%, respectively. 3e7 In addition, arterial allografts 8e14 and superficial femoral vein autografts 15e17 have been used in situ at the site of infection. However, publications regarding the use venous allografts for graft infection have been scarce. Our department has extensive experience in using venous allografts since 1997. 18 The aim of the present research is to analyze the results of treatment of synthetic vascular graft infection with venous allografts.
Patients and Methods

Patients
During 1997e2006 we treated 11 male patients with venous allografts for the treatment of aorto-femoral segment prosthetic graft infection. During surgery we used venous allografts removed during varicose vein surgery for in situ revascularization. The average diameter of the harvested veins were 8e9 mm. The average age of patients at the time of diagnosing synthetic graft infection was 63.5 AE 7.5 years (range 45e75 years). The indication for the primary operation was occlusive disease in the aortoiliac segment in ten cases and posttraumatic pseudoaneurysm of the iliac artery in one case ( Table 1) .
The interval between the implantation of synthetic vascular graft and the appearance of infection was 43 AE 29 months (range 5 monthse10 years). Seven of the 11 patients had required further reconstructive operations during there follow-up to treat progressive atherosclerosis. The clinical signs of vascular synthetic graft infection of these patients are presented in Table 2 . In all cases, Doppler ultrasound and CT scan revealed a thin layer of liquid around the synthetic graft; perigraft abscess or collection. Digital subtraction angiography was not used any cases.
Vein harvesting
We used great saphenous veins removed during varicose vein surgery using a flexible intraluminal phleboextractor. Our previous experience has demonstrated that only the femoral part of great saphenous vein is useful for reconstruction of the aorta. The accepted average diameter were 8e9 mm. We avoid the use of areas with varicosities and clear inflammation changes. In two cases we oversewed local varicosities of 1 cm in length. In more severe varicosities we resected and re-anastomosed the vein segment. Either tube or aorto-bifemoral grafts were produced from the good quality venous segments. In 6 cases we combined different veins for allograft construction (all aorto-bifemoral cases). Venous allografts were preserved in isotonic saline (0.9% NaCl), which also contained heparin and ampicillin, at 4 C for up to 15 days. All donors had been tested for hepatitis B and C as well as for HIV types 1 and 2. ABO/Rh system compatibility was not attempted in any of the cases. Ethical approval and informed consent were obtained from donors and recipients for venous allografting and HIV testing.
Surgical procedures
Two patients required emergency surgical treatment for bleeding from groin fistulae. Elective surgery was performed in nine patients.
In all cases the circulation to lower extremities was restored in situ using venous allografts that had been removed during varicose vein surgery. The venous allografts was prepared on the previous day or immediately before surgery. In all cases distal anastomoses of the synthetic transplant were first dissected in the groin. Total laparotomy was then performed and the proximal anastomosis of the synthetic vascular graft was found. In aorto-bifemoral or aorto-femoral bypasses the aorta was clamped at the left renal vein and distal flow was blocked using a balloon occlusion catheter. In the ilio-femoral bypass cases the common iliac artery was clamped near the aortic bifurgation. In all cases retrograde flow from deep femoral and superficial femoral arteries were controlled with balloon occlusion catheters.
The infected synthetic vascular graft was next removed. The proximal anastomosis of a new allotransplant (aortobifemoral, aorto-femoral or ilio-femoral bypass) was established at the site of the proximal anastomosis of the previous synthetic vascular graft and the distal anastomoses were performed to the femoral arteries. During surgery samples were examined microscopically to guide the extent of the graft infection. As far as possible, debridement was performed to normal tissues and the compartment of infected synthetic vascular graft was rinsed with polyvinoliodide solution. Vacuum drains were left in the region of all anastomoses. Drains were removed when less than 10 ml was discharged within 24 hours.
Continuous suture with 3/0e4/0 polypropylene was used for all anastomoses. Heparin 40 IU/kg was administered intraoperatively. Post-operatively no anticoagulants or immunosuppressants were used (Table 3) .
All patients received intravenous antibiotics for a mean of 8 AE 2 days (range 5e12 days) after surgery. If the causative agent of the synthetic vascular graft infection was known preoperatively, antibiotic treatment was prescribed according to sensitivities (3 cases). In emergency situations (2 cases) the initial empiric antibacterial treatment was prescribed according to microscopy findings. Preoperative antibacterial treatment was not prescribed to patients (3 cases) who did not have fever, leukocytosis and increased CRP. In three cases in which the infective agent was unknown preoperative antibacterial treatment with second and third generation cephalosporins was commenced, because the patients presented the clinical signs of septic shock. The duration of preoperative antibacterial treatment was four days on average. The indicators for stopping postoperative antibiotic therapy were the normalization of temperature, leukocytosis and CRP.
All patients were subject to regular follow-up at intervals of 6 months which included clinical examination and Doppler ultrasound. A graft was considered patent if Doppler ultrasound confirmed patency.
Statistical analysis
Clinical information was tabulated for all patients. Lifetable method was used to calculate primary patency and limb salvage rates.
Results
Bacteriology
Cultures for bacteriological testing were collected preoperatively from three patients with purulent groin fistulae, from two patients with a history of bleeding from groin fistulae and from three patients with groin abscesses. Intraoperatively cultures for bacteriological testing were taken from the infected graft and surrounding tissue during all 11 operations.
Microbiological culture was positive in 3 out of 8 patients (38%) preoperatively and in 6 out of 11 patients postoperatively (55%). Staphylococci were most commonly isolated (4 cases out of 11, 36%) but MRSA was not present in any of the cases. Fungi were isolated in none of the cases. In 46% of the cases classical microbial cultures failed to identify a pathogen (Fig. 1) .
Early (up to 30 days) results
The mean duration of follow-up was 59 AE 37 (range 13e102) months. None of the patients died during the early postoperative period. One patient required ventilation for one day during the immediate postoperative period. During the postoperative period, there were no cases of bleeding in the region of anastomoses and no wound complications. One patient needed trans-femoral amputation due to gangrene of the lower extremity 12 days prior to the Trans-femoral amputation was performed in one patient six months after allograft implantation due to thrombosis of aorto-bifemoral bypass branch and peripheral thrombosis as a result of haemoconcentration and distal junction stenosis. At the same stage angioplasty of the distal anastomosis of the contralateral branch with patch was performed for a stenosis.
One patient was hospitalized 40 months after aortobifemoral bypass implantation due to the occlusion of one limb of aorto-bifemoral bypass and acute ischemia caused by thromboembolism from left atrium. Successful thrombectomy was performed, but ischemic damage of peroneal nerve persisted.
One patient required additional femoro-popliteal bypass with a venous allograft six months after ileo-femoral grafting due to progression of occlusive disease. The following surgical procedures were performed in one patient in addition to the aorto-bifemoral venous allograft: femoro-popliteal bypass one month later; thrombectomy from the right limb of aorto-bifemoral bypass 29 months later, thrombectomy from the left limb of aorto-bifemoral bypass along with deep femoral arterioplasty 32 months later and again thrombectomy from the left limb of aortobifemoral bypass along with additional femoro-popliteal bypass 62 months later. All these additional surgical procedures were required because of very rapid progression of peripheral arterial disease.
The primary cumulative patency of the venous allografts were 100%, 88%, 66.3% and 55.2% after one month, six months, three years and eight years, respectively ( Fig. 2A) . Secondary patency rates were 94.1% and 73.2% at 1 and 8 years, respectively. Overall survival rate was 100%, 63.6%, 45.5% and 27.3% after one month, 3, 5 and 8 years, respectively. Limb salvage rates were 100%, 94% and 73% after one month, 5 years and 8 years, respectively (Fig. 2B ).
Discussion
The early postoperative (up to 30 days) and 10 years followup results of our study reflect the safety and efficacy of venous allografts in the treatment of synthetic graft infection in the aorto-femoral segment. The incidence of amputation following synthetic vascular graft infection treated during the whole period was 5.9%. This is comparable in with similar studies previously published (Table 4) .
In the present study the causative agent of synthetic vascular graft infection remained unverified in 45% of the cases. We would like to point out two significant factors: Preoperative antibacterial treatment and biofilm-forming microbes with low virulence that conventional microbiological methods fail to culture.
Our department has extensive and positive experience in using venous allografts removed during varicose vein surgery since 1978, 18 however, we lack experience using Rifampicin-bonded and Silver-coated grafts.
Davies and Parums claimed that from the morphological aspect the best medium for preserving allografts is saline at 4 C, as the basal membrane and collagen matrix are maintained. 19 Another advantage of preservation in saline at 4
C over other techniques is rapid disappearance of endothelial cells. This limits rejection reactions that can lead to occlusion. 19 Preserving allografts at 4 C causes exfoliation of the endothelial cells and reduces the amount smooth muscle cells in the medium. 20 The low incidence of graft rejection using venous allografts may be due to the lack of HLA-II antigen expression in the wall of large vessels. The rejection process involves cell-mediated immunity to venous allografts and is not eliminated with low-dose azathioprine. There is also indirect evidence of participation of humoral immunity in venous allograft rejection. 21 None of the venous allografts we used were matched for ABO or HLA antigens, however, we did not find evidence of graft rejection. The graft patency rate was 77% after 8 years.
We had no re-infection in the study group. Allografts may have more intensive antimicrobial activity compared to synthetic grafts, because they are preserved in antibiotic solutions and for example, in the research of Vogt et al. and Teebken et al. antibiotic-containing fibrin adhesive was used to cover allograft anastomoses. 10, 13 In situ reconstruction with autologous superficial femoral vein has so far been the most effective way for preventing re-infection, but this type of surgery is problematic in emergency situations due to the additional amount of time required. 14, 16, 22 Also, this type of surgery is contraindicated in the case of previous deep vein thrombosis and up to 12% of patients may develop postoperative compartment syndrome. 17 Yeager et al. reported that extraanatomical reconstruction is associated with >25% rate of secondary complications. 23 In addition, there is a significant incidence of re-infection (3e10%). 22, 23 Based on our small series the use of allografts formed from varictomized alloveins in situ for the treatment of synthetic graft infection in the aorto-femoral segment has Figure 3 Left side venous allograft ilio-femoral bypass after 8 years, proximal anastomosis end to end, distal anastomosis end to side (CT-angiography). 
